Atherosclerosis of coronary artery bypass grafts and smoking

Area of Science:

• Cardiovascular Surgery
• Vascular Medicine
• Smoking Cessation Research

Background:

• Coronary artery bypass surgery (CABS) is a critical intervention for severe coronary artery disease.
• Graft patency and long-term outcomes after CABS are influenced by various patient factors, including lifestyle choices like smoking.
• Understanding the impact of continued smoking on graft health post-CABS is crucial for patient management.

Purpose of the Study:

• To evaluate the long-term patency and health of coronary artery bypass grafts in patients who continued to smoke versus those who did not.
• To assess the association between smoking status and the development of atherosclerosis and occlusion in bypass grafts.

Main Methods:

• Follow-up angiography was conducted on 340 male patients after coronary artery bypass surgery.
• 1160 grafts were initially assessed, with 112 excluded due to early occlusion.
• Grafts were analyzed for irregularities, patency, and signs of disease over a 5-year period, comparing smokers (115 patients) and nonsmokers (225 patients).

Main Results:

• Disease-free grafts were observed in 39% of smokers compared to 52% of nonsmokers.
• Smokers exhibited a significantly higher proportion of diseased or occluded grafts than nonsmokers.
• The mean number of grafts per patient was similar between the smoking and nonsmoking groups.

Conclusions:

• Continued smoking after coronary artery bypass surgery is associated with a significantly greater risk of graft atherosclerosis and occlusion.
• While this study did not assess smoking cessation effectiveness, it strongly suggests that maintaining a nonsmoking status is vital for long-term graft survival post-CABS.
• These findings underscore the importance of smoking cessation counseling and support for patients undergoing or having undergone coronary artery bypass surgery.